Prevention of myofilament dysfunction by β-blocker therapy in postinfarct remodeling

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Dirk J. Duncker - , Erasmus University Rotterdam (Autor:in)
  • Nicky M. Boontje - , Vrije Universiteit Amsterdam (VU) (Autor:in)
  • Daphne Merkus - , Erasmus University Rotterdam (Autor:in)
  • Amanda Versteilen - , Vrije Universiteit Amsterdam (VU) (Autor:in)
  • Judith Krysiak - , Westfälische Wilhelms-Universität Münster (Autor:in)
  • Giulia Mearini - , Universität Hamburg (Autor:in)
  • Ali El-Armouche - , Universitätsklinikum Hamburg-Eppendorf (UKE) (Autor:in)
  • Vincent J. De Beer - , Erasmus University Rotterdam (Autor:in)
  • Jos M.J. Lamers - , Erasmus University Rotterdam (Autor:in)
  • Lucie Carrier - , Universität Hamburg, INSERM - Institut national de la santé et de la recherche médicale (Autor:in)
  • Lori A. Walker - , University of Colorado Anschutz Medical Campus (Autor:in)
  • Wolfgang A. Linke - , Westfälische Wilhelms-Universität Münster (Autor:in)
  • Ger J.M. Stienen - , Vrije Universiteit Amsterdam (VU) (Autor:in)
  • Jolanda Van Der Velden - , Vrije Universiteit Amsterdam (VU) (Autor:in)

Abstract

Background-Myofilament contractility of individual cardiomyocytes is depressed in remote noninfarcted myocardium and contributes to global left ventricular pump dysfunction after myocardial infarction (MI). Here, we investigated whether β-blocker therapy could restore myofilament contractility. Methods and Results-In pigs with a MI induced by ligation of the left circumflex coronary artery, β-blocker therapy (bisoprolol, MI+β) was initiated on the first day after MI. Remote left ventricular subendocardial biopsies were taken 3 weeks after sham or MI surgery. Isometric force was measured in single permeabilized cardiomyocytes. Maximal force (Fmax) was lower, whereas Ca2+ sensitivity was higher in untreated MI compared with sham (both P<0.05). The difference in Ca2+ sensitivity was abolished by treatment of cells with the β-adrenergic kinase, protein kinase A. β-blocker therapy partially reversed F max and Ca2+ sensitivity to sham values and significantly reduced passive force. Despite the lower myofilament Ca2+ sensitivity in MI+β compared with untreated myocardium, the protein kinase A induced reduction in Ca2+sensitivity was largest in cardiomyocytes from myocardium treated with β-blockers. Phosphorylation of β-adrenergic target proteins (myosin binding protein C and troponin I) did not differ among groups, whereas myosin light chain 2 phosphorylation was reduced in MI, which coincided with increased expression of protein phosphatase 1. β-blockade fully restored the latter alterations and significantly reduced expression of protein phosphatase 2a. Conclusions-β-blockade reversed myofilament dysfunction and enhanced myofilament responsiveness to protein kinase A in remote myocardium after MI. These effects likely contribute to the beneficial effects of β-blockade on global left ventricular function after MI.

Details

OriginalspracheEnglisch
Seiten (von - bis)233-242
Seitenumfang10
FachzeitschriftCirculation: Heart Failure
Jahrgang2
Ausgabenummer3
PublikationsstatusVeröffentlicht - Mai 2009
Peer-Review-StatusJa
Extern publiziertJa

Externe IDs

PubMed 19808345
ORCID /0000-0003-2514-9429/work/187084981

Schlagworte

Schlagwörter

  • β-blockers, Contractility, Myocardial infarction, Myofilament proteins, Phosphatases